Table 5.
Correlations of AIx with clinical variables and cardiovascular risk factors in relation to TOAST stroke subtype
| |
Lacunar |
|
LAAS |
|
CEI |
|
|||
|---|---|---|---|---|---|---|---|---|---|
| Variable |
Augmentation Index (AIx) |
p
|
Augmentation Index (AIx) |
p
|
Augmentation Index (AIx) |
p
|
|||
| With metabolic syndrome (n: 45) | Without metabolic syndrome (n: 37) | 0 | With metabolic syndrome (n: 45) | Without metabolic syndrome (n: 37) | With metabolic syndrome (n:32) | Without metabolic syndrome (n:35) | |||
|
CRP |
0.24 |
0.26 |
0.73 |
0.27 |
0.26 |
0.81 |
0.20 |
0.21 |
0.73 |
|
IL-1-β |
0.21 |
0.22 |
0.60 |
0.24 |
0.25 |
0.66 |
0.20 |
0.22 |
0.56 |
|
IL-6 |
0.31 |
0.25 |
0.026 |
0.34 |
0.226 |
0.011 |
0.33 |
0.23 |
0.022 |
|
TNF-α |
0.33 |
0.27 |
0.022 |
0.32 |
0.26 |
0.033 |
0.32 |
0.26 |
0.033 |
| E-selectin |
0.20 |
0.27 |
0.56 |
0.19 |
0.21 |
0.56 |
0.19 |
0.21 |
0.56 |
| P-selectin |
0.19 |
0.15 |
0.33 |
0.18 |
0.16 |
0.44 |
0.18 |
0.16 |
0.44 |
| VICAM-1 |
0.21 |
0.22 |
0.66 |
0.22 |
0.21 |
0.66 |
0.20 |
0.22 |
0.66 |
| ICAM-1 |
0.22 |
0.24 |
0.63 |
0.20 |
0.24 |
0.63 |
0.22 |
0.24 |
0.63 |
| IL-10 |
0.22 |
0. 23 |
0.56 |
0.22 |
0. 23 |
0.56 |
0.22 |
0. 23 |
0.56 |
|
vWF |
0.36 |
0.30 |
0.020 |
0.33 |
0.27 |
0.029 |
0.36 |
0.32 |
0.018 |
| PAI-1 |
0.19 |
0.14 |
0.64 |
0.16 |
0.14 |
0.77 |
0.18 |
0.15 |
0.77 |
| TPA |
0.22 |
0.25 |
0.77 |
0.20 |
0.21 |
0.69 |
0.20 |
0.21 |
0.69 |
| |
|
|
|
|
|
|
|
|
<0.05 |
| 0.033 | |||||||||
Coefficients (r) and p-values are calculated by the Pearson correlation mode.
SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial pressure; AIx: augmentation index; PWV: pulse wave velocity; SSS: Scandinavian Stroke Scale score; NIHSS: National Institutes of Health Stroke Scale ; Angiotensin II receptor blockers (ARBs); CAD: coronary artery disease; CHF: congestive heart failure; LVH: left ventricular hypertrophy; WMHLS: white matter hypertension lesions. Demographic and history data are expressed as n° (percentage). Significant R and p are in bold.